Additionally, in ER-positive breast cancers, NOP14 increases the level of ERα via NRIP1, suggesting an interesting insight for future studies to improve the endocrinotherapy effects on breast cancer patients and lead to better prognosis. This evidence concerns the gene ESR1 and breast cancer.